EARNINGS PER SHARE

3 Months Ended

Dec. 31, 2021

Net Loss per share:

NOTE 16 - EARNINGS PER SHARE

NOTE 16 – EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share for the following periods:

	Three Months Ended
	December 31,			December 31,
	2021			2020
Basic:
Net income (loss) continuing operations	$	(19,160,904	)	$	(9,395,621	)
Preferred dividends paid		1,000,502			100,050
Net income (loss) continuing operations adjusted for preferred dividend		(20,161,406	)		(9,495,671	)
Net income (loss) attributable to cbdMD Inc. common shareholders		(20,161,406	)		(9,495,671	)
Diluted:
Net income (loss) continuing operations		(20,161,406	)		(9,395,621	)
Net income (loss)		(20,161,406	)		(9,395,621	)
Shares used in computing basic earnings per share		57,825,367			52,130,870
Effect of dilutive securities:
Options		-			-
Warrants		-			-
Convertible preferred shares		-			-
Shares used in computing diluted earnings per share		57,825,367			52,130,870
Earnings per share Basic:
Continued operations		(0.35	)		(0.18	)
Discontinued operations		-			-
Basic earnings per share		(0.35	)		(0.18	)
Earnings per share Dliuted:					-
Continued operations		(0.35	)		(0.18	)
Discontinued operations		-			-
Diluted earnings per share		(0.35	)		(0.18	)

At the three months ended December 31 2021, 4,082,500 potential shares underlying options, unvested RSUs and warrants as well as 8,335,000 convertible preferred shares were excluded from the shares used to calculate diluted loss per share as their inclusion would reduce net loss per share.